kimmtrak
immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastické činidlá - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
sansik
zentiva, k.s., Česká republika - linagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
linagliptin viatris
viatris limited, Írsko - linagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
ilinpru 5 mg
viatris limited, Írsko - linagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
tantum verde spray
angelini pharma Österreich gmbh, rakúsko - benzydamín - 69 - otorhinolaryngologica
tantum verde spray forte
angelini pharma Österreich gmbh, rakúsko - benzydamín - 69 - otorhinolaryngologica
tantum verde 0,15 %
angelini pharma Österreich gmbh, rakúsko - benzydamín - 69 - otorhinolaryngologica
alavistm curenzym enzymoterapia
avaglim
smithkline beecham ltd - rosiglitazone, glimepiride - diabetes mellitus, typ 2 - lieky používané pri cukrovke - avaglim je indikovaný v liečbe diabetes mellitus 2. typu u pacientov, ktorí nie sú schopní dosiahnuť dostatočné glykemický kontroly na optimálne dávkovanie sulfonylmocoviny monotherapy, a pre ktorých je metformín je nevhodné z dôvodu kontraindikácie alebo neznášanlivosti.
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastické činidlá - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.